Yennurajalingam, Sriram
Lu, Zhanni
Chen, Minxing
Bruera, Eduardo
Article History
Received: 31 March 2021
Accepted: 29 August 2021
First Online: 12 October 2021
Declarations
:
: The University of Texas MD Anderson Cancer Center Institutional Review Board approved the protocol<b>.</b>
: Institutional Review Board waived the informed consent for this retrospective study.
: Institutional Review Board waived the informed consent for this retrospective study.
: The authors declare no conflict of interest related to study. Sriram Yennurajalingam, Helsinn (research funding for fatigue study), Bayer (research funding for fatigue study), Genentech (research funding for palliative care study); and Eduardo Bruera (Helsinn: research funding for palliative care study). All other authors declare no conflict of interest.
Free to read: This content has been made available to all.